Patents by Inventor Carla R. McGill

Carla R. McGill has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6761915
    Abstract: Reducing heartburn episodes is achieved in individuals having an orange juice intolerance or food allergy. The orange juice product has a low titratable acidity which combines with a condition resulting after addition of a calcium source such as a calcium citrate source. Individuals prone to orange juice induced heartburn episodes experience a reduced incidence of these heartburn episodes.
    Type: Grant
    Filed: March 31, 2003
    Date of Patent: July 13, 2004
    Assignee: Tropicana Products, Inc.
    Inventors: Richard N. McArdle, Carla R. McGill, Stephen A. Letourneau, Nancy R. Green
  • Patent number: 6682767
    Abstract: Reducing heartburn episodes is achieved in individuals having an orange juice intolerance or food allergy. The orange juice product has a low titratable acidity and a low oil condition, which can be combined with addition of a calcium source. Individuals prone to orange juice induced heartburn episodes experience a reduced incidence of heartburn episodes.
    Type: Grant
    Filed: May 3, 2001
    Date of Patent: January 27, 2004
    Assignee: Tropicana Products, Inc.
    Inventors: Richard N. McArdle, Stephen A. Letourneau, Carla R. McGill, Cindy L. Hart, Albert D. Bolles
  • Publication number: 20040013786
    Abstract: Reducing heartburn episodes is achieved in individuals having an orange juice intolerance or food allergy. The orange juice product has a low oil condition, which optionally can be combined with addition of a calcium source. Individuals prone to orange juice induced heartburn episodes experience a reduced incidence of heartburn episodes when they ingest the juice.
    Type: Application
    Filed: May 7, 2003
    Publication date: January 22, 2004
    Inventors: Richard N. McArdle, Stephen A. Letourneau, Albert D. Bolles, Carla R. McGill, Nancy P. Green
  • Patent number: 6565898
    Abstract: Reducing heartburn episodes is achieved in individuals having an orange juice intolerance or food allergy. The orange juice product has a low titratable acidity which combines with a condition resulting after addition of a calcium source such as a calcium citrate source. Individuals prone to orange juice induced heartburn episodes experience a reduced incidence of these heartburn episodes.
    Type: Grant
    Filed: May 3, 2001
    Date of Patent: May 20, 2003
    Assignee: Tropicana Products, Inc.
    Inventors: Richard N. McArdle, Carla R. McGill, Stephen A. Letourneau, Nancy R. Green
  • Publication number: 20030021876
    Abstract: Reducing heartburn episodes is achieved in individuals having an orange juice intolerance or food allergy. The orange juice product has a low titratable acidity and a low oil condition, which can be combined with addition of a calcium source. Individuals prone to orange juice induced heartburn episodes experience a reduced incidence of heartburn episodes.
    Type: Application
    Filed: May 3, 2001
    Publication date: January 30, 2003
    Inventors: Richard N. McArdle, Stephen A. Letourneau, Carla R. McGill, Cindy L. Hart, Albert D. Bolles
  • Publication number: 20020192309
    Abstract: Reducing heartburn episodes is achieved in individuals having an orange juice intolerance or food allergy. The orange juice product has a low titratable acidity which combines with a condition resulting after addition of a calcium source such as a calcium citrate source. Individuals prone to orange juice induced heartburn episodes experience a reduced incidence of these heartburn episodes.
    Type: Application
    Filed: May 3, 2001
    Publication date: December 19, 2002
    Inventors: Richard N. McArdle, Carla R. McGill, Stephen A. Letourneau, Nancy R. Green
  • Publication number: 20020006953
    Abstract: Methods, products and compositions are provided which, when administered to a mammal, including humans, raises HDL serum cholesterol levels, while typically also lowering the ratio of LDL to HDL serum cholesterol levels. An effective amount of one or more of a monoterpene, a terpene and a flavonoid are included in the treatment composition.
    Type: Application
    Filed: November 5, 1999
    Publication date: January 17, 2002
    Inventors: CARLA R. MCGILL, NANCY R. GREEN